Possibilities of art therapy and color therapy in the rehabilitation of multiple sclerosis

THE PURPOSE OF THE STUDY: To study the effectiveness of non-drug methods of prevention and rehabilitation of patients with various variants of multiple sclerosis (MS) in outpatient settings.

MATERIAL AND METHODS: In a group of 35 patients with limited mobility with various variants of the course of MS, continuous art therapy was performed (art lectures, work with various art materials - markers, pastels, etc.). The average duration of the training cycle in the group was 6 months. Classes were held on an outpatient basis, and if it was impossible to attend classes - remotely.

RESULTS: Positive results were obtained in double psychological testing. 68% of patients had decreased levels of depression and anxiety on the HADS scale, 34% of patients refused to take antidepressants. However, positive psychotherapeutic dynamics against the background of art therapy is not a reason to cancel the main basic treatment.

CONCLUSION: Art therapy-art therapy and, as its division, color therapy (diagnosis of the condition and treatment of color) is a synthesis of medicine, art and psychology. In MS patients, the following color combinations are recommended when working with art materials:stimulating (red, orange, coral, yellow); soothing (green, blue, blue, purple). Negative colors are excluded - black, gray, dirty shades with a mixture of black or gray.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:121

Enthalten in:

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 121(2021), 7. Vyp. 2 vom: 15., Seite 49-55

Sprache:

Russisch

Weiterer Titel:

Vozmozhnosti art-terapii i tsvetoterapii v reabilitatsii pri rasseyannom skleroze

Beteiligte Personen:

Guseva, M E [VerfasserIn]
Matveevskaya, O V [VerfasserIn]
Sivertseva, S A [VerfasserIn]
Boyko, O V [VerfasserIn]

Links:

Volltext

Themen:

Antidepressants
Art therapy
Color therapy
Depression
Journal Article
Multiple sclerosis

Anmerkungen:

Date Completed 17.08.2021

Date Revised 17.08.2021

published: Print

Citation Status MEDLINE

doi:

10.17116/jnevro202112107249

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM32931226X